Search Results
Site Search
Ingenuity, collaboration, and expertise create a game-changing COVID-19 test swab - Insights
A massive effort culminated in Mayo Clinic designing, testing and mass-manufacturing a 3D-printed mid-turbinate swab for COVID-19 testing.
Osmotic fragility testing - Insights
In this month’s “Hot Topic,” James Hoyer, M.D., discusses the importance of using a control tube during osmotic fragility testing.
New tests launched in September - Insights
In September 2022, Mayo Clinic Laboratories announced ten new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights
Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.
Genetics - Mayo Clinic Laboratories
Our genetic testing was developed by experienced geneticists, genetic counselors, laboratory scientists, and bioinformaticians. We focus on providing easy to understand answers, interpreted by those same individuals who have an intimate...
After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency...
Mayo Clinic Laboratory and Pathology Research Roundup: March 12 - Insights
This week’s Research Roundup highlights cardiovascular concerns in BRCA1 and BRCA2 mutation carriers.
Allan Jaffe, M.D., Discusses Use of Highly Sensitive Cardiac Troponin in CAP Today - Insights
Allan Jaffe, M.D., Consultant and Chair of Mayo Clinic’s Division of Clinical Core Laboratory Services, with a joint appointment in the Division of Cardiovascular Diseases, spoke with CAP Today about what a new higher-sensitivity cardiac...
MCL - Stool Collection Instructions - MC5424-21
MCL - Stool Collection Instructions - PATIENT EDUCATION Stool Collection Instructions read material start stool collection Collect stool
Testing Archives - Page 6 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Accurately characterize marijuana use through urine THC testing - Insights
Paul Jannetto, Ph.D., and Loralie Langman, Ph.D., discuss Mayo Clinic Laboratories’ new marijuana monitoring evaluation, which identifies metabolites of both delta-9 tetrahydrocannabinol (THC) and delta-8 THC to accurately identify and...
Gynecological cancer - Insights
Find out how our gynecological cancer panels evaluate genes with relevance to diagnosing and treating uterine, ovarian, and endometrial cancers.
Elevating accuracy of Alzheimer's testing - Insights
Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.
B-cell and T-cell acute lymphoblastic leukemia - Insights
Find out how our suite of B-cell and T-cell acute lymphoblastic leukemia tests can detect genetic subgroups and assist in treatment selection.
Examining dendritic cells to uncover immunity defects - Insights
Dendritic cells play a crucial role in the body's immune response. Research has shown that too few of these cells in the blood may signal a defect in innate immunity. Up to this point, however, no clinical test has been available to count...
Week in Review: April 29 - Insights
Today's highlights include: CDC estimates 3 in 4 kids have had coronavirus infections, virtual in-person cardiac rehabilitation provide similar benefits, and Mayo Clinic partners with AI startup to co-develop precision medicine.
Behind the scenes in neural antibody testing - Insights
In this month’s “Hot Topic,” John Mills, Ph.D., explains the central role of tissue immunofluorescence in the identification of neural antibodies and discusses the benefits of an integrated laboratory approach to the development and...
CPT Codes and LOINC Update: September 2020 - Insights
The following list includes updates posted to mayocliniclabs.com during the month of September
Five Steps to Improve Transfusion Medicine - Insights
Blood transfusion is the most common procedure performed in hospitals in the U.S. Yet published evidence shows significant gaps in clinicians' knowledge of this critical aspect of patient care, including possible adverse reactions that can...
Pushing the envelope on personalized medicine - Insights
Recognizing the powerful role genes can play in diagnosing illness and guiding treatment, the Division of Laboratory Genetics and Genomics at Mayo Clinic spearheaded a testing expansion, implementing and upgrading more than 60 advanced...
Defying all odds and exploring a remarkable journey beyond diagnosis: Mike Knudson - Insights
In August of 2021, 28-year-old Mike Knudson, a Twin Cities resident known for his vibrant and active lifestyle, set out on what he anticipated to be an adventurous hiking vacation to the picturesque Glacier National Park in Montana. Little...
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 11 - Insights
This week’s Research Roundup highlights autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease.
Alicia Algeciras-Schimnich, Ph.D., discusses Mayo Clinic Laboratories’ new noninvasive plasma biomarker assay for Alzheimer’s disease, an accessible, highly accurate testing option for individuals age 50 and above who are experiencing mild...
Algorithms - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Testing Archives - Page 4 of 26 - Insights
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Skip to Content MayoACCESS MayoLINK Register My Dashboard...
Testing for systemic lupus erythematosus (SLE) and related antiphospholipid syndrome (APS) at Mayo Clinic Laboratories is performed by experienced laboratory scientists and testing experts with decades of experience diagnosing autoimmune...
Our suite of preeclampsia, prenatal, breast and gynecological cancer, and other testing has been developed in collaboration with clinical leaders in a variety of women’s health specialties to provide accurate, actionable results.
It delivers insights that put patients on the right pathway. It drives revenue that can bolster the financial stability of the hospital. It elevates the standards of care in the communities it serves – but only if you recognize your lab’s...
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
One Test, Multiple Targets: Zeroing in on Autoimmune Movement Disorders - Insights
A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.
Mayo Clinic Laboratories has launched a first-in-the-U.S. autoimmune test of the Kelchlike protein 11 antibody, or KLHL11, which is used to detect autoimmune disease associated with testicular cancer.
October 2023 - Pulmonary Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Pulmonary Pathology.
Plasma-Cell Neoplasms - Mayo Clinic Laboratories
As a pioneer in the field, Mayo Clinic plays an integral role by developing new tests to help align patients with new therapies for plasma cell disorders.
Mayo Clinic Laboratories cerebrospinal fluid metagenomic testing uses shotgun metagenomic sequencing to interrogate all microbial DNA and RNA present in a sample and determine the presence of potential pathogens.
Rapid response: COVID-19, monkeypox, and whatever comes next - Insights
Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in...
Patient Information and Signature Forms - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Lyme Disease, Part 2: Borrelia mayonii-A New Cause of Lyme Disease in Upper Midwest - Insights
In this “Hot Topic,” Bobbi Pritt, M.D., discusses how Lyme disease is the most common vector-borne illness in the United States and Europe and caused primarily by Borrelia burgdorferi in the United States, while B burgdorferi, B afzelii,...
Autoimmune Encephalopathy Testing - Mayo Clinic Laboratories
Our phenotype specific testing for autoimmune encephalopathy contains only clinically relevant antibodies providing accurate answers for treatment guidance.
Patient Information and Signature Forms - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
MAYO AZ out of state testing approval updated.pdf
Out of State Testing 899 North Capitol Street NE | 2nd Fl, Washington, DC 20002 | P 202-724-8800 | F 202-724-8677 | dchealth.dc.gov Date: August 11, 2023 RE: Out of State Testing Approval HFD-OS35 MAYO CLINIC MOLECULAR DIAGNOSTICS AZ is...
NGS for Myeloid Neoplasm Evaluation - Insights
In this month's "Hot Topic," David Viswanatha, M.D., discusses updates to Mayo Clinic's next-generation sequencing (NGS) for myeloid neoplasm evaluation, involving new test targets, the rationale for new genetic regions, alignments with the...
Performed on cerebrospinal fluid, Mayo Clinic’s RT-QuIC prion test can distinguish prion disease from other types of rapidly progressive dementias to enhance patient care.
Present Approaches to Testing - Insights
Discussing current test applications that you can implement in your laboratory or practice today.
Genetic Testing to Enhance Multiple Myeloma Treatment - Insights
Multiple myeloma is the second most common blood cancer, but most people haven’t heard of it until they or someone they know is diagnosed with the disease. March is Myeloma Action Month—a time to focus attention on the fight against...
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Our experts discuss the latest from Mayo Clinic Laboratories, so you can stay up to date on the most advanced diagnostics and newly developed tests. Note: Podcasts will not play back on Internet Explorer. Please use an alternative web...
Our serum test is the first preeclampsia-specific test that can be used to stratify patients into low- or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features.
Post-Bulletin Features Dr. Bobbi Pritt's "Creepy, Dreadful, Wonderful Parasites" Blog - Insights
The Rochester Post-Bulletin recently highlighted Bobbi Pritt, M.D.'s, “Creepy, Dreadful, Wonderful Parasites” blog, which celebrated its 10-year anniversary in October with a parasite-themed art contest and giveaways.